Leah A Cohn

Title: Leah A. Cohn: Innovator in Cystic Fibrosis Treatment

Introduction

Leah A. Cohn is a prominent inventor based in Columbia, MO (US). She has made significant contributions to the field of medical research, particularly in the treatment of cystic fibrosis. Her innovative approach has led to the development of a unique therapeutic method that addresses this challenging condition.

Latest Patents

Leah A. Cohn holds a patent for her work titled "Genistein for the treatment of cystic fibrosis." This patent describes a method of treating cystic fibrosis by generating cystic fibrosis transmembrane conductance regulator (CFTR) function in cells containing mutant CFTR. The therapeutic composition involves administering an effective amount of genistein, or its analogues and derivatives, to individuals afflicted with cystic fibrosis. This groundbreaking work has the potential to improve the quality of life for many patients.

Career Highlights

Cohn is affiliated with the University of Missouri, where she continues her research and development efforts. Her dedication to advancing medical science is evident in her innovative work and commitment to finding effective treatments for cystic fibrosis.

Collaborations

Leah A. Cohn has collaborated with notable colleagues, including Tzyh-Chang Hwang and Arnold L. Smith. These partnerships have enhanced her research and contributed to the advancement of her patented methods.

Conclusion

Leah A. Cohn's contributions to the treatment of cystic fibrosis through her innovative patent demonstrate her commitment to improving patient outcomes. Her work at the University of Missouri and collaborations with esteemed colleagues highlight her role as a leading inventor in the medical field.